Johnson & Johnson

Also known as: Johnson & Johnson

United States

2 Trials

Johnson & Johnson is tracked as an institutional-capital stakeholder relevant to financing exposure in psychedelic and adjacent mental-health sectors.

Academic Research

0 papers

Published Papers

Trial Involvement

Distinct Focus Topics

Latest Publication

Unknown

Investor Snapshot

Institutional Investors

Classification

Institutional Investor

Geography

Global

Coverage

Global

Last Verified

Apr 17, 2026

Investment Stage Focus

Growth / Late StagePublic MarketsMulti-Stage

Investment Focus Areas

Drug Development

Investor Notes

Added from user-provided legacy investor list and retained with cross-tag-safe categorization. Public positioning appears psychedelic-adjacent and requires deeper deal-level verification.

Verification

Unverified

Psychedelic Focus

Psychedelic-Adjacent Focus

Engagement Status

Active

Primary Investment Link

Source Evidence

Johnson & Johnson - Official Website

https://www.jnj.com/